IBRX - ImmunityBio, Inc.
2.61
-0.080 -3.065%
Share volume: 3,296,891
Last Updated: 04-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.69
-0.08
-0.03%
Summary score
39%
Profitability
43%
Dept financing
25%
Liquidity
74%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
32.73%
Return on assets
-24.82%
Return on sales
-125789.44%
Return on invested capital
-52.79%
Total debt ratio
225.2%
Debt ratio change over timeo
0.65%
Current Ratio
1.85%
Quick Ratio
1.72%
Cash Position Ratio
1.44%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-16.44%
Return on sales
-62427.67%
Return on invested capital
0%
Total debt ratio
265.5%
Debt ratio change over timeo
-2.78%
Current Ratio
3.4%
Quick Ratio
3.24%
Cash Position Ratio
2.25%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.95%
Return on sales
-918.96%
Return on invested capital
0%
Total debt ratio
227.72%
Debt ratio change over time
0%
Current Ratio
3.36%
Quick Ratio
3.21%
Cash Position Ratio
2.61%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.35%
Return on assets
-116.05%
Return on sales
-214373.37%
Return on invested capital
-34%
Total debt ratio
64.85%
Debt ratio change over time
0.65%
Current Ratio
-1.02%
Quick Ratio
-0.82%
Cash Position Ratio
-1.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IBRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 32.73% | 18.63% | 6.54% | 4.69% |
| Return on assets | -24.82% | 3.07% | 3.1% | 2.44% |
| Return on sales | -125789.44% | 30.43% | 28.58% | 24.11% |
| Return on invested capital | -52.79% | 5.33% | 3.53% | 4.44% |
| Profitability | 25% | 89% | 70% | 64% |
| Total debt ratio | 225.2% | 92.23% | 67.28% | 47.95% |
| Debt ratio change over time | 0.65% | 20.48% | 134.64% | 15.7% |
| Dept financing | 25% | 14% | 32% | 8% |
| Current Ratio | 3.4% | 1.32% | 1.27% | 1.75% |
| Quick Ratio | 3.24% | 0.95% | 1.11% | 1.13% |
| Cash Position Ratio | 2.25% | 0.47% | 0.47% | 0.42% |
| Liquididy | 72% | 56% | 42% | 62% |
| Short-term ratios | IBRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -16.44% | 2.13% | 0.76% | 2.05% |
| Return on sales | -62427.67% | 21.39% | 4.39% | 23.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 48% | 14% | 49% |
| Total debt ratio | 265.5% | 93.35% | 67.02% | 41.52% |
| Debt ratio change over time | -2.78% | 0% | 15.75% | 0% |
| Dept financing | 25% | 9% | 31% | 4% |
| Current Ratio | 3.4% | 1.32% | 1.27% | 1.75% |
| Quick Ratio | 3.24% | 0.95% | 1.11% | 1.13% |
| Cash Position Ratio | 2.25% | 0.47% | 0.47% | 0.42% |
| Liquididy | 75% | 22% | 23% | 26% |
